Semler Scientific, Inc. short interest in 2023
In 2023, Semler Scientific, Inc.'s disclosed short interest ran from 0.62% of shares outstanding on 13 Jan 2023 to 2.79% on 29 Dec 2023, a change of +2.17 percentage points. The year's high was 5.08% on 15 Sep 2023 and its low 0.35% on 31 Jan 2023, averaging 3.06% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.30 days on 31 Jul 2023. Full history: Semler Scientific, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025
2023 in figures
- Start of year
- 0.62% (13 Jan 2023)
- End of year
- 2.79% (29 Dec 2023)
- Change
- +2.17 pp
- High
- 5.08% (15 Sep 2023)
- Low
- 0.35% (31 Jan 2023)
- Average
- 3.06%
- Highest days to cover
- 10.30 (31 Jul 2023)
- SEC filings marked
- 9
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 0.62% | 2.12 | |
| 31 Jan 2023 | 0.35% | 1.00 | |
| 31 Mar 2023 | 2.32% | 3.98 | results (8-K), 10-K filed |
| 14 Apr 2023 | 2.27% | 3.73 | |
| 28 Apr 2023 | 2.21% | 4.19 | |
| 15 May 2023 | 2.78% | 4.18 | results (8-K), 10-Q filed |
| 31 May 2023 | 2.87% | 4.76 | |
| 15 Jun 2023 | 2.89% | 4.44 | |
| 30 Jun 2023 | 4.28% | 2.48 | |
| 14 Jul 2023 | 4.26% | 9.46 | results (8-K) |
| 31 Jul 2023 | 3.94% | 10.30 | |
| 15 Aug 2023 | 4.19% | 3.89 | results (8-K), 10-Q filed |
| 31 Aug 2023 | 4.88% | 10.25 | |
| 15 Sep 2023 | 5.08% | 5.83 | |
| 29 Sep 2023 | 3.26% | 3.33 | |
| 13 Oct 2023 | 3.38% | 3.93 | |
| 31 Oct 2023 | 3.13% | 6.07 | |
| 15 Nov 2023 | 3.00% | 4.82 | results (8-K), 10-Q filed |
| 30 Nov 2023 | 2.72% | 3.75 | |
| 15 Dec 2023 | 2.96% | 2.57 | |
| 29 Dec 2023 | 2.79% | 4.89 |
See also: Semler Scientific, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.